Yoshiba M, Yamada H, Yoshikawa Y, Fujiwara K, Toda G, Oka H, Sanjo T, Yamazaki Z, Idezuki Y, Inoue N
Artif Organs. 1986 Oct;10(5):417-9. doi: 10.1111/j.1525-1594.1986.tb02590.x.
Based on the assumption that middle molecules that induce hepatic coma occur in the plasma of patients with fulminant hepatic failure (FHF), the authors have developed a hemodiafiltration (HDF) method using a large-pore poly(methylmethacrylate) (PMMA) membrane that allows proteins to pass through. PMMA HDF resulted in complete recovery of deep coma and long-term survival in a patient with severe FHF. Although a large-scale controlled trial is needed, PMMA HDF is believed to be promising as a future artificial liver support.
基于暴发性肝衰竭(FHF)患者血浆中存在诱导肝昏迷的中分子物质这一假设,作者开发了一种血液透析滤过(HDF)方法,该方法使用能让蛋白质通过的大孔聚甲基丙烯酸甲酯(PMMA)膜。PMMA HDF使一名严重FHF患者的深度昏迷完全恢复并长期存活。尽管需要大规模对照试验,但PMMA HDF被认为是一种有前景的未来人工肝支持方法。